Trevor Glanville
Adult Health · New York, NYNPI 1326703091
Payments from drug & device makers
Across 435 payments — averaging $28.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- MML US, Inc.$2K
- Boston Scientific$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$942
- AbbVie$792
- Collegium Pharmaceutical, Inc.$745
- plus $2K from 22 others
What the payments were for
- Travel & lodging$7866%
- Food & beverage$11,72394%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 107 | $4,407 |
| MML US, Inc. | 54 | $1,674 |
| Boston Scientific | 17 | $1,508 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 79 | $942 |
| AbbVie(2 entities) | 39 | $792 |
| Collegium Pharmaceutical, Inc. | 45 | $745 |
| Kowa Pharmaceuticals America, Inc. | 16 | $394 |
| Pfizer | 13 | $282 |
| Relievant Medsystems, Inc. | 4 | $227 |
| Tersera Therapeutics LLC | 9 | $188 |
| Amgen | 7 | $150 |
| Johnson & Johnson | 1 | $149 |
| Merz Pharmaceuticals, LLC | 3 | $145 |
| Scilex Pharmaceuticals Inc. | 6 | $128 |
| Augmedics Inc. | 1 | $126 |
| Forte Bio-pharma LLC | 6 | $124 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $107 |
| Almatica Pharma LLC | 5 | $88 |
| Protega Pharmaceutials Inc | 4 | $65 |
| Amneal Pharmaceuticals LLC | 3 | $55 |
| Cerapedics Inc. | 2 | $45 |
| Hikma Pharmaceuticals USA | 2 | $40 |
| GRT US Holding, Inc. | 2 | $38 |
| Si-bone, Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Stryker | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Medline Industries LP | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,506
- INTELLIS ADAPTIVESTIM$1,070
- SPECTRA WAVEWRITER$1,017
- ReActiv8$788
- Intracept$700
- Xvision$631
- Superion Indirect Decompression System$170
- INCEPTIV$155
- ASCENDA$151
- Teligen$149
- WaveWriter Alpha Prime 16$146
- VANTA ADAPTIVESTIM$141
How this compares
$12,527 in reported general payments places this provider in the 95th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RoxybondOxycodone Hcl | 39 | $67,870 |
| OxycontinOxycodone Hcl | 35 | $51,567 |
| RelistorMethylnaltrexone Bromide | 13 | $30,425 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 210 | $28,573 |
| Xtampza ErOxycodone Myristate | 42 | $25,904 |
| BelbucaBuprenorphine Hcl | 29 | $23,897 |
| Diclofenac Sodium | 52 | $11,961 |
| Morphine Sulfate ErMorphine Sulfate | 113 | $9,792 |
| LinzessLinaclotide | 14 | $8,459 |
| Ibuprofen-FamotidineIbuprofen/Famotidine | 33 | $8,380 |
| Diclofenac Potassium | 24 | $7,512 |
| Lidocaine | 48 | $6,864 |
| Oxycodone Hcl | 340 | $6,273 |
| MovantikNaloxegol Oxalate | 11 | $4,342 |
| Fentanyl | 44 | $3,581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Protega Pharmaceutials IncRoxybond | $65 | $67,87039 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $745 | $49,80171 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $942 | $30,42513 claims |
| AbbVieLinzess | $792 | $8,45914 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $40 | $2,35996 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,828 adult health providers in New York.
Other adult health in New York
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Alyson HartyNew York$65K
- Laura GraaflandNew York$51K
- Allysa SaggeseNew York$49K
- Juliet EscalonNew York$46K
- Teshmanie RampersaudNew York$23K
- Jenna WenzelNew York$22K
- Elizabeth SavageNew York$20K
- Libby LevineNew York$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.